Retraction Note: Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.

The article "Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis" by W.-X. Lu published in Eur Rev Med Pharmacol Sci 2019; 23 (17): 7356-7368-DOI: 10.26355/eurrev_201909_18842-PMID: 31539122 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (https://pubpeer.com/publications/1CE3437CE3D1F5CA10D8494E9EFEE2), the Journal has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal's investigation identified multiple instances of figure duplication, specifically in panel C of Figure 9, with previously published articles. Additionally, a duplication was also found in the Western Blots of Figure 8 with a previously published article. The author was contacted and informed of the ongoing investigation, and was requested to provide the original data supporting the manuscript, but remained unresponsive. As a result, the Journal has decided to retract this article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18842.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-10-01
DOI
https://doi.org/10.26355/eurrev_202510_37461
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retraction Note: Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.

Wei Lu
PubMed
Cancer-related molecular mechanisms research
article

Retraction Note: Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.

Wei Lu
article en

Abstract

The article "Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis" by W.-X. Lu published in Eur Rev Med Pharmacol Sci 2019; 23 (17): 7356-7368-DOI: 10.26355/eurrev_201909_18842-PMID: 31539122 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (https://pubpeer.com/publications/1CE3437CE3D1F5CA10D8494E9EFEE2), the Journal has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal's investigation identified multiple instances of figure duplication, specifically in panel C of Figure 9, with previously published articles. Additionally, a duplication was also found in the Western Blots of Figure 8 with a previously published article. The author was contacted and informed of the ongoing investigation, and was requested to provide the original data supporting the manuscript, but remained unresponsive. As a result, the Journal has decided to retract this article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18842.

PubMedVol. 29(10)
Jiangsu Province Hospital (CN)
Openalex Percentile: Top 60%
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.